Market Overview   There has been steady growth in the biologics market owing to an increase in the incidence of chronic illnesses, high demand for customized medications, developments in biotech industry, and huge investments in research & development. Biologics comprise of highly complex medications that are manufactured using living cells such as bacteria, yeast, animals, or plants. Some examples of biologics include monoclonal antibodies, vaccines, recombinant proteins, gene therapy, and cellular therapy Key Trends Shaping the Market   Increased acceptance of monoclonal antibody therapy   Increased demand for personalized/precision medicine   Emergence of biosimilar products   Significant investment in gene & cell therapies   Use of biologics in oncology treatments   Advancements in biopharmaceutical manufacturing technology   Regulatory approval of innovative biologics   Treatment of rare diseases gaining importance Critical Methods of Analysis Used for this Report   Estimation and prediction of market sizes (2026-2036).   Calculating compound annual growth rate and growth trends.   Estimation of revenue growth.   Value Chain and Supply Chain Analysis.   Competitive analysis.   Demand forecast.   Pipeline/Product Portfolio Analysis.   Innovation/technology adoption analysis.